Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis
- 1 March 2002
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 109 (3), 547-555
- https://doi.org/10.1067/mai.2002.121832
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Tacrolimus: A new topical immunomodulatory therapy for atopic dermatitisJournal of Allergy and Clinical Immunology, 2001
- Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitisJournal of Allergy and Clinical Immunology, 2001
- The eczema area and severity index (EASI): assessment of reliability in atopic dermatitisExperimental Dermatology, 2001
- A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in childrenJournal of Allergy and Clinical Immunology, 1998
- Tacrolimus Ointment does not Affect Collagen Synthesis: Results of a Single-Center Randomized TrialJournal of Investigative Dermatology, 1998
- Disease Management of Atopic Dermatitis: a Practice ParameterAnnals of Allergy, Asthma & Immunology, 1997
- III phase comparative test for FK506 salve. Intergroup comparative test for atopic dermatitis ( trunk and limb ) with betamethasone valerate salve.The Nishinihon Journal of Dermatology, 1997
- Anti-Inflammatory Effect of FK-506 on Human Skin Mast CellsJournal of Investigative Dermatology, 1992
- Topical glucocorticoids with improved benefit/risk ratio: Do they exist?Journal of the American Academy of Dermatology, 1992
- Clinical Trial Comparing Hydrocortisone 17-Butyrate to Betamethasone 17-Valerate in a Series of Patients with Eczematous Skin DiseasesDermatology, 1976